High-titer collapsin response-mediating protein-associated (CRMP-5) paraneoplastic optic neuropathy and vitritis as the only clinical manifestations in a patient with small cell lung carcinoma

Journal of Neuro-Ophthalmology

Volumn 28, Issue 1, 2008, Pages 17-22

  Margolin, Edward ^a   Flint, Andrew ^a   Trobe, Jonathan D ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN 5; ETOPOSIDE; METHYLPREDNISOLONE; UNCLASSIFIED DRUG;

AGED; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DISEASE ASSOCIATION; DRUG TREATMENT FAILURE; EYE EXAMINATION; EYE INFLAMMATION; FEMALE; FOLLOW UP; HUMAN; LUNG SMALL CELL CANCER; OPTIC NERVE DISEASE; PAPILLEDEMA; PARANEOPLASTIC NEUROPATHY; PRIORITY JOURNAL; RETINA FLUORESCEIN ANGIOGRAPHY; VISUAL ACUITY; VITRITIS;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SMALL CELL; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; LYMPH NODES; NERVE TISSUE PROTEINS; NEURAL CELL ADHESION MOLECULES; OPTIC DISK; OPTIC NERVE DISEASES; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; RADIOTHERAPY; RETINAL ARTERY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; VISION, LOW; VITREOUS BODY;

EID: 40949109723     PISSN: 10708022     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNO.0b013e3181675479     Document Type: Article

References (20)

1. Bataller L, Dalmau JO. Paraneoplastic disorders of the central nervous system: update on diagnostic criteria and treatment. Semin Neurol 2004;24:461-7.
2. Cross SA, Salomao DR, Parisi JE, et al. Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG. Ann Neurol 2003;54:38-50.
3. Sheorajpanday R, Slabbynck H, Van De Sompel W, et al. Small cell lung carcinoma presenting as collapsin response-mediating protein (CRMP)-5 paraneoplastic optic neuropathy. J Neuroophthalmol 2006;26:168-72.
4. Thambisetty MR, Scherzer CR, Yu Z, et al. Paraneoplastic optic neuropathy and cerebellar ataxia with small cell carcinoma of the lung. J Neuroophthalmol 2001;21:164-7.
5. Yu Z, Kryzer TJ, Griesmann GE, et al. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 2001;49:146-54.
6. Ares-Luque A, Garcia-Tunon LA, Saiz A, et al. Isolated paraneoplastic optic neuropathy associated with small-cell lung cancer and anti-CV2 antibodies. J Neurol 2007;254:1131-2.
7. Calvert PC. A CR(I)MP in the optic nerve: recognition and implications of paraneoplastic optic neuropathy. J Neuroophthalmol 2006;26:165-7.
8. Ducray F, Roos-Weil R, Garcia PY, et al. Devic's syndrome-like phenotype associated with thymoma and anti-CV2/CRMP5 antibodies. J Neurol Neurosurg Psychiatry 2007;78:325-7.
9. Kuroda Y, Miyahara M, Sakemi T, et al. Autopsy report of acute necrotizing opticomyelopathy associated with thyroid cancer. J Neurol Sci 1993;120:29-32.
10. Vernino S, Tuite P, Adler CH, et al. Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma. Ann Neurol 2002;51:625-30.
11. Hoogenraad TU, Sanders EA, Tan KE. Paraneoplastic optic neuropathy with histopathological verification of absence of meningeal metastases. Neuroophthalmology 1989;9:247-50.
12. Malik S, Furlan AJ, Sweeney PJ, et al. Optic neuropathy: a rare paraneoplastic syndrome. J Clin Neuroophthalmol 1992;12:137-41.
13. Samii A, Dahlen DD, Spence AM, et al. Paraneoplastic movement disorder in a patient with non-Hodgkin's lymphoma and CRMP-5 autoantibody. Mov Disord 2003;18:1556-8.
14. Pittock SJ, Kryzer TJ, Lennon VA. Paraneoplastic antibodies coexist and predict cancer not neurological syndrome. Ann Neurol 2004;56:715-9.
15. Sillevis Smitt PA, Vecht CJ. Treatment of paraneoplastic neurological syndromes. In: Noseworthy JH, ed. Neurological Therapeutics: Principles and Practice 2nd ed. Milton Park, Abington, Oxon, UK: Informa Healthcare; 2006:832-42.
16. Keltner JL, Thirkill CE, Tyler NK, et al. Management and monitoring of cancer-associated retinopathy. Arch Ophthalmol 1992;110:48-53.
17. Murphy MA, Thirkill CE, Hart WM Jr. Paraneoplastic retinopathy: a novel auto-antibody reaction associated with small-cell lung carcinoma. J Neuroophthalmol 1997;17:77-83.
18. Guy J, Aptsiauri N. Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases. Arch Ophthalmol 1999;117:471-7.
19. Keime-Guibert F, Graus F, Fleury A, et al. Treatment of paraneoplastic neurologic syndromes with antineuronal antibodies (anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J Neurol Neurosurg Psychiatry 2000;68:479-82.
20. Luiz JE, Lee AG, Keltner JL, et al. Paraneoplastic optic neuropathy and autoantibody production in small-cell carcinoma of the lung. J Neuroophthalmol 1998;18:178-81.